Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-27 23:32:52 - browse：61574

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： The most pressing bird flu mysteries scientists want answered

WSS

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Covid’s new normal has set in amid another rise in cases

FDA weighs limits of animal data in assessing artificial wombs

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Fed up with FDA, ALS advocates consider a take

BD to buy Edwards patient monitoring unit for $4.2 billion

hotspot

Wikipedia

hotspot

Peter Hotez and the public health issue of online harassment

Patients, doctors press FTC to beef up hospital merger scrutiny

Medical records are filled with copy

The most pressing bird flu mysteries scientists want answered

Novavax promises a turnaround & Lilly roils the obesity market

Medicare Advantage's lean provider networks lead CMS complaints

Medical leaders decry Supreme Court decision on affirmative action

What happened to the House vote on health price transparency?

Walensky prepares to leave CDC — and Congress — behind

Medicare to pay more for cardiac rehab in hospital outpatient clinics

focus

Congress needs to close a vaccine

Sutter Health’s antitrust win overturned by appeals court

House panel takes first step toward fixing drug shortages

A new initiative will help leaders fight the next pandemic

The unintended consequences of overturning Roe v. Wade

Senators tussle over abortion against the backdrop of a presidential campaign

knowledge

Wikipedia

hotspot

focus